Commercial due diligence on healthcare businesses
For investors in hospitals, clinic groups, pharmacies, laboratories and the companies that supply them.
Healthcare in the capital markets
Healthcare listings raised $508 million across the Gulf in 2025, including SMC Hospitals on the Saudi Main Market and Basma Adeem and Wajd Life on Nomu [1]. Listed valuations give private buyers a reference point, and sellers know it.
That makes it more important to know whether a target's growth comes from the market or from a few doctors, a few contracts or a single location.
What we test
Typical questions on a healthcare target
Doctors, not just beds
In many clinic groups a small number of consultants drive a large share of revenue. If they leave, patients often follow. We look at how revenue splits by clinician, how long key people have been there, and what keeps them.
For expansion plans, we test whether the new locations have the patient demand, the payer contracts and the staff to open on time.
Questions
Do you speak to patients?
Rarely, and only with care. We usually learn more from referrers, insurers, corporate clients and staff.
Do you cover medical devices and pharmaceuticals?
Yes, including distributors, where agency agreements and tender wins drive the plan.